Bank Of Montreal Karuna Therapeutics, Inc. Transaction History

Bank Of Montreal

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 08, 2024	BUY	$161.01 - $317.85 $111,257 - $219,634	691 New	691 $218,000
Q2 2023 Aug 02, 2023	SELL	$176.32 - $240.22 $385,082 - $524,640	-2,184 Reduced 15.54%	11,868 $2.57 Million
Q1 2023 Jun 13, 2024	BUY	$161.33 - $204.36 $2.08 Million - $2.63 Million	12,893 New	12,893 $2.34 Million
Q4 2022 Feb 01, 2023	SELL	$191.53 - $236.82 $750,989 - $928,571	-3,921 Reduced 21.82%	14,052 $2.76 Million
Q3 2022 Nov 10, 2022	BUY	$123.79 - $277.42 $928,177 - $2.08 Million	7,498 Added 71.58%	17,973 $4.11 Million
Q2 2022 Aug 11, 2022	BUY	$93.97 - $143.33 $984,335 - $1.5 Million	10,475 New	10,475 $1.28 Million

332K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

Stay updated on Bank Of Montreal with notifications on news.